caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1790786879

Chad AmossonMD

PRACTICERADIANT MEDICAL VENTURESSee all providers at this practice →
Radiation OncologyPlano, TXI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Chad Amosson's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 7 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Mandar Joshi
Diagnostic Radiology · Arlington, TX
47573
GANDHI, NEELU29474
TEXAS HEALTH ARLINGTON MEMORIAL HOSPITAL26510
TEXAS HEALTH PRESBYTERIAN HOSPITAL DALLAS26474
Alfred Di Stefano
Hematology-Oncology · Arlington, TX
18898
Barry Firstenberg
Internal Medicine · Grapevine, TX
12732
Won Kim
Diagnostic Radiology · Fort Worth, TX
11163
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,126
Unique beneficiaries
—
Total services
8,402
Distinct HCPCS
13
Medicare payment
$1.6M
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 329 Radiation Oncology providers in TX — top quintile (cohort median 1,836).
PRESCRIBING · PART D · 2024
Total Rx claims
206
Beneficiaries
—
Total drug cost
$171K
Distinct drugs
3
Brand share
31.6%
Top prescribed drugs
Tamsulosin Hcl125 claims
Relugolix65 claims
Bicalutamide16 claims
QUALITY · MIPS · 2024
Final MIPS score
90.1
Quality
97.5
Cost
69.6
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.64%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$101
Payment records
5
By payment type
Food and Beverage$101